Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 3
1975 10
1976 9
1977 17
1978 17
1979 17
1980 12
1981 15
1982 11
1983 7
1984 15
1985 10
1986 26
1987 15
1988 29
1989 21
1990 26
1991 17
1992 15
1993 10
1994 22
1995 9
1996 7
1997 3
1998 6
1999 7
2000 9
2001 9
2002 10
2003 4
2004 3
2005 4
2006 2
2007 4
2008 1
2009 5
2010 3
2011 2
2012 6
2013 6
2014 4
2015 2
2016 1
2017 1
2018 1
2019 2
2020 2
2021 1
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

434 results

Results by year

Filters applied: . Clear all
Page 1
Tinnitus.
Hazell JW. Hazell JW. Br J Hosp Med. 1979 Nov;22(5):468-71. Br J Hosp Med. 1979. PMID: 395984 Review. No abstract available.
Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis.
Girolami B, Bernardi E, Prins MH, Ten Cate JW, Hettiarachchi R, Prandoni P, Girolami A, Büller HR. Girolami B, et al. Arch Intern Med. 1999 Feb 22;159(4):337-45. doi: 10.1001/archinte.159.4.337. Arch Intern Med. 1999. PMID: 10030306 Review.
BACKGROUND: There is no consensus on the efficacy of physical training, smoking cessation, and pharmacological therapy (pentoxifylline or nafronyl oxalate) in the treatment of patients with intermittent claudication at Fontaine stage II of disease. ...Only level 3 studies …
BACKGROUND: There is no consensus on the efficacy of physical training, smoking cessation, and pharmacological therapy (pentoxifylline or …
Bioanalyses and pharmacokinetics of nafronyl in the dog.
Garrett ER. Garrett ER. J Pharm Sci. 1984 May;73(5):635-49. doi: 10.1002/jps.2600730514. J Pharm Sci. 1984. PMID: 6737238
Improved specific and sensitive reverse-phase HPLC assays of nafronyl (I) and its acidic metabolite and hydrolysis product (II) in biological fluids were developed with sensitivities of 3-6 ng/mL using fluorometric detection with 225 nm excitation and 330 nm emission wavel …
Improved specific and sensitive reverse-phase HPLC assays of nafronyl (I) and its acidic metabolite and hydrolysis product (II) in bi …
Claudication.
Ruckley VC. Ruckley VC. Br Med J (Clin Res Ed). 1986 Apr 12;292(6526):970-1. doi: 10.1136/bmj.292.6526.970. Br Med J (Clin Res Ed). 1986. PMID: 3083974 Free PMC article. No abstract available.
Naftidrofuryl for dementia.
Lu D, Song H, Hao Z, Wu T, McCleery J. Lu D, et al. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD002955. doi: 10.1002/14651858.CD002955.pub4. Cochrane Database Syst Rev. 2011. PMID: 22161372 Review.
Nafronyl ion-selective membrane electrodes and their use in pharmaceutical analysis.
Ionescu MS, Badea V, Baiulescu GE, Coşofreţ VV. Ionescu MS, et al. Talanta. 1986 Jan;33(1):101-3. doi: 10.1016/0039-9140(86)80021-2. Talanta. 1986. PMID: 18964041
A simple potentiometric method is described for the rapid determination of nafronyl-drugs in pharmaceutical preparations such as tablets. Nafronyl ion-selective membrane electrodes with either the nafronyl-dipicrylamine ion-pair complex in 1,2-dichloroethane …
A simple potentiometric method is described for the rapid determination of nafronyl-drugs in pharmaceutical preparations such as tabl …
Effects of delayed treatment with nafronyl oxalate on microsphere embolism-induced changes in monoamine levels of rat brain regions.
Takagi N, Miyake K, Ohiwa A, Nukaga R, Takeo S. Takagi N, et al. Br J Pharmacol. 1996 May;118(1):33-40. doi: 10.1111/j.1476-5381.1996.tb15363.x. Br J Pharmacol. 1996. PMID: 8733573 Free PMC article.
The present study was undertaken to examine the effects of delayed treatment with nafronyl oxalate (nafronyl), a cerebral vasodilator, on monoamine neurotransmitters of brain regions in the microsphere-embolized rat. 2. ...On days 3 and 5, the decrease in the monoam …
The present study was undertaken to examine the effects of delayed treatment with nafronyl oxalate (nafronyl), a cerebral vaso …
Effect of nafronyl on lactate and pyruvate in the cerebrospinal fluid of patients with senile dementia.
Yesavage JA, Tinklenberg JR, Hollister LE, Berger PA. Yesavage JA, et al. J Am Geriatr Soc. 1982 Feb;30(2):105-8. doi: 10.1111/j.1532-5415.1982.tb01283.x. J Am Geriatr Soc. 1982. PMID: 6173407
In a single-blind study, 12 men (mean age 63 years) with senile dementia were given nafronyl in a dosage of 100 mg eight times daily for a week, followed by 100 mg four times daily for 12 weeks. ...
In a single-blind study, 12 men (mean age 63 years) with senile dementia were given nafronyl in a dosage of 100 mg eight times daily …
Prediction of stability in pharmaceutical preparations XVIII: application of high-pressure liquid chromatographic assays to study of nafronyl stability and bioanalysis.
Garrett ER, Barbhaiya R. Garrett ER, et al. J Pharm Sci. 1981 Jan;70(1):39-45. doi: 10.1002/jps.2600700106. J Pharm Sci. 1981. PMID: 7229928
Nafronyl is hydrolyzed by specific hydrogen-ion (15.2 kcal/mole) and hydroxide-ion (7.72 kcal/mole) catalysis of the neutral species and specific hydroxide-ion catalysis (5.91 kcal/mole) of the protonated species. ...Since nafronyl has a half-life of 3.2 hr in hepar …
Nafronyl is hydrolyzed by specific hydrogen-ion (15.2 kcal/mole) and hydroxide-ion (7.72 kcal/mole) catalysis of the neutral species …
434 results